Inder K. Daftari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Inder K. Daftari has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Jessica Elizabeth Scholey
Department of Radiology and Biomedical Imaging University of California San Francisco San Francisco California USA
3 shared publications - Kavita K. Mishra
UCSF Osher Center for Integrative Health, Proton Ocular Radiation Oncology, Osher Foundation Endowed Chair in Clinical Programs in Integrative Health, University of California San Francisco, San Francisco, CA
3 shared publications - Armin R. Afshar
Ocular Oncology Service, Department of Ophthalmology, Wayne & Gladys Valley Center for Vision, University of California, San Francisco, San Francisco, CA, USA
2 shared publications Devron H. Char
The Tumori Foundation, San Francisco, California
2 shared publications- Alejandro Mazal
Centro de Protonterapia Quironsalud, Madrid, SPAIN
1 shared publication - Alessia Pica
Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, 5232 Villigen, Switzerland
1 shared publication
Latest Publications
- Open Access
Long-Term Clinical Outcomes for Adolescent and Young-Adult Uveal Melanoma Patients Treated with Dedicated Particle-Beam Radiation
Uveal melanoma (UM) is a rare tumor and a challenging diagnosis for adolescent and young-adult (AYA) patients, as it can threaten vision, quality of life, and life expectancy
Open AccessLong-Term Clinical Outcomes for Adolescent and Young-Adult Uveal Melanoma Patients Treated with Dedicated Particle-Beam Radiation
Uveal melanoma (UM) is a rare tumor and a challenging diagnosis for adolescent and young-adult (AYA) patients, as it can threaten vision, quality of life, and life expectancy
- 23 September 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Solid-State Circuits
- Vol. 55 (11) , 2947-2958
A Millimeter-Scale Single Charged Particle Dosimeter for Cancer Radiotherapy
This article presents a millimeter-scale CMOS 64 × 64 single charged particle radiation detector system for external beam cancer radiotherapy. A 1 × 1 μm 2 diode measures energy deposition by a single charged particle in the depletion region, and the array design provides a large detection area of 512 × 512 μm 2 . Instead of sensing the voltage drop caused by radiation, the proposed system measures the pulsewidth, i.e., the time it takes for the voltage to return to its baseline. This obviates the need for using power-hungry and large analog-to-digital converters. A prototype application-specific integrated circuit (ASIC) is fabricated in TSMC 65-nm LP CMOS process and consumes the average static power of 0.535 mW under 1.2-V analog and digital power supply. The functionality of the whole system is successfully verified in a clinical 67.5-MeV proton beam setting. To our knowledge, this is the first work to demonstrate single charged particle detection for implantable in vivo dosimetry.
- 23 September 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Solid-State Circuits
- Vol. 55 (11) , 2947-2958
A Millimeter-Scale Single Charged Particle Dosimeter for Cancer Radiotherapy
This article presents a millimeter-scale CMOS 64 × 64 single charged particle radiation detector system for external beam cancer radiotherapy. A 1 × 1 μm 2 diode measures energy deposition by a single charged particle in the depletion region, and the array design provides a large detection area of 512 × 512 μm 2 . Instead of sensing the voltage drop caused by radiation, the proposed system measures the pulsewidth, i.e., the time it takes for the voltage to return to its baseline. This obviates the need for using power-hungry and large analog-to-digital converters. A prototype application-specific integrated circuit (ASIC) is fabricated in TSMC 65-nm LP CMOS process and consumes the average static power of 0.535 mW under 1.2-V analog and digital power supply. The functionality of the whole system is successfully verified in a clinical 67.5-MeV proton beam setting. To our knowledge, this is the first work to demonstrate single charged particle detection for implantable in vivo dosimetry.
- Open Access
- 1 July 2020
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 5 (4) , 682-686
Practice Considerations for Proton Beam Radiation Therapy of Uveal Melanoma During the Coronavirus Disease Pandemic: Particle Therapy Co-Operative Group Ocular Experience
- 1 July 2020
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 5 (4) , 682-686
Open AccessPractice Considerations for Proton Beam Radiation Therapy of Uveal Melanoma During the Coronavirus Disease Pandemic: Particle Therapy Co-Operative Group Ocular Experience